UPADACITINIB — all Canadian products
3 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is UPADACITINIB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02495155 | RINVOQ | ABBVIE CORPORATION | Tablet (Extended-Release) | Oral | UPADACITINIB 15 MG | Marketed | |
| 02520893 | RINVOQ | ABBVIE CORPORATION | Tablet (Extended-Release) | Oral | UPADACITINIB 30 MG | Marketed | |
| 02539721 | RINVOQ | ABBVIE CORPORATION | Tablet (Extended-Release) | Oral | UPADACITINIB 45 MG | Marketed |
Browse other molecules: